Glaucoma and the Silent Warning Symptoms

Early Glaucoma Has No Symptoms. So How Do You Know You Have It? Dr Shibal Bhartiya explains who is at…

Glaucoma And Mental Health

Dr Shibal Bhartiya, fellowship trained glaucoma specialist, explains Glaucoma And Mental Health, and The Emotional Side of Glaucoma: Anxiety, Depression,…

Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya, best Glaucoma specialist in Gurgaon, India.

Fellowship-trained. Research-backed. Focused entirely on protecting your long-term vision.

Glaucoma is one of the leading causes of irreversible blindness in India. It is silent, slow, and often diagnosed late. Finding the right specialist, someone trained specifically in glaucoma, not just ophthalmology in general, makes a significant difference to your long-term vision.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist in Gurgaon, currently serving as Clinical Director of Ophthalmology at Marengo Asia Hospitals, Sector 56, Gurugram; and as Research Collaborator, Mayo Clinic, Jacksonville, Florida, USA. She brings over two decades of focused glaucoma experience and international standards to glaucoma care- from early detection and medical management to complex surgery, for every patient she sees.

Why a Glaucoma Subspecialist Matters

Most ophthalmologists manage a wide range of eye conditions. A glaucoma specialist has additional fellowship training specifically in glaucoma: its diagnosis, progression, risk patterns, and treatment across every stage of disease.

This distinction matters because glaucoma requires:

  • Careful interpretation of tests over time, not just single reports
  • Risk stratification: understanding your lifetime probability of vision loss
  • Precise treatment timing: too early, too late, or too aggressive all carry consequences
  • Long-term monitoring that evolves with your disease
  • Surgical expertise across the full spectrum: from medical management to lasers to MIGS to complex tube shunts

A general eye check can miss early glaucoma. A specialist is trained to find it. Which is why a second opinion with a glaucoma specialist matters.

Have an emergency/quick query

WhatsApp +91 98187 00269

Get an appointment now

Call +91 88826 38735, +91 98187 00269

Training & Credentials

Dr Shibal Bhartiya is one of the best glaucoma specialists in Gurgaon, India. Her glaucoma training spans some of the world’s most respected institutions:

Fellowship Training

  • Clinical Research Fellowship in Glaucoma, University of Geneva, Switzerland (Clinique d’Ophtalmologie, Department of Clinical Neurosciences, Hôpitaux Universitaires de Genève). She was also enrolled for a Doctorat en Medicin at the University.
  • Senior Clinical Research Associate, Cornea and Glaucoma Services, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi.

Current Research

  • Research Collaborator, Mayo Clinic, Jacksonville, Florida, USA (from September 2024)
  • Active clinical trials in glaucoma medication adherence, Quality of life, lifestyle determinants of disease, IOP monitoring, community-based glaucoma screening and surgical outcomes
  • Collaborations in research with glaucoma specialists from over 20 countries across the globe

Academic Leadership

Publications

  • Peer-reviewed research indexed on PubMed and Google Scholar, including published work on the ethics of glaucoma practice and long-term management decision-making
  • Multiple best paper awards at international glaucoma congresses (APAO, Asia Pacific Glaucoma Congress, International Society for Glaucoma Surgery)
  • Edited more than 20 textbooks on glaucoma, and ophthalmology; and contributed chapters to more than 20 other textbooks

Full list of publications can be accessed here

Glaucoma Conditions Treated

Dr Bhartiya, best glaucoma specialist in Gurgaon, manages the full spectrum of glaucoma- from the earliest suspicion of disease to advanced and complex cases:

Glaucoma Suspects & Early Disease

Established Glaucoma

  • Primary open-angle glaucoma (POAG)
  • Normal-tension glaucoma, where pressure is normal but damage occurs
  • Primary angle-closure glaucoma and angle-closure suspects
  • Secondary glaucomas: following trauma, retinal surgery, corneal transplant (keratoplasty), steroid use, uveitis, or other conditions

Complex & Advanced Glaucoma

Neuro-Ophthalmology & Glaucoma Overlap

How Glaucoma Care Works Here

Glaucoma management is not a single event. It is a long-term relationship between a patient and a specialist who understands the full arc of their disease.

1. Comprehensive First Assessment

The first consultation includes a detailed history, careful optic nerve evaluation, review of all available reports, and a full risk assessment. We do not rush this appointment.

2. Test Interpretation: Not Just Repetition

OCT scans, visual fields, eye pressure readings, and corneal thickness measurements are interpreted in context, not in isolation. Single test results can mislead. Patterns over time reveal the truth.

3. Risk Stratification

Two patients with the same eye pressure can have very different lifetime risk. We assess your individual risk based on optic nerve structure, field changes, age, family history, systemic health, and rate of progression.

4. Target Pressure: Individual, Not Generic

Your target eye pressure is specific to you: based on your optic nerve health, how fast your disease is progressing, your age, and how much vision you need to protect. It is not a fixed number. It evolves.

5. Treatment Explained Clearly

Whether the recommendation is observation, eye drops, laser, MIGS, or conventional surgery; the reasoning is explained fully. You will understand why a treatment is being recommended, what happens if you choose differently, and what the long-term plan looks like.

6. Long-Term Follow-Up Plan

At the end of every consultation, you will know: how often to return, what tests to repeat, what symptoms to watch for, and what progression would mean for your treatment.

Treatment Options: Full Spectrum

Medical Management

  • Evidence-based prescribing of the right drop, at the right time, for the right patient
  • Monitoring for side effects and compliance challenges
  • Combination therapy when single agents are insufficient
  • Fixed-dose combinations to reduce drop burden

Laser Treatment

Surgical Management

  • Minimally Invasive Glaucoma Surgery (MIGS): for mild to moderate disease, often combined with cataract surgery
  • Trabeculectomy: the gold standard filtration surgery for moderate to advanced glaucoma
  • Tube shunts and drainage devices: for complex and refractory cases
  • Revision surgery and bleb rescue: when prior procedures have failed

Surgery is never the first answer. But when it is needed, it is performed with precision and explained fully in advance.

Who Should See a Glaucoma Specialist in Gurgaon

You should consider a glaucoma specialist if:

  • You have been told you may have glaucoma, or are a glaucoma suspect
  • You have a family history of glaucoma
  • Your eye pressure has been found to be elevated
  • You are over 40 with risk factors like myopia, diabetes, hypertension, or thyroid disease
  • Your optic nerve looks different on a routine exam
  • You have been on glaucoma drops for years without a thorough review
  • You are approaching a decision about glaucoma surgery and want full clarity
  • You want a second opinion on your diagnosis, test results, or treatment plan

Many patients come simply because something does not feel clear. That is reason enough.

Serving Gurgaon and Across Delhi NCR

Dr Bhartiya’s clinic is located at Marengo Asia Hospitals, Golf Course Extension Road, Sector 56, Gurugram, easily accessible from across Delhi NCR.

Patients travel from South Delhi, Faridabad, Noida, Dwarka, Vasant Kunj, and Greater Noida for specialist glaucoma consultations. For patients who live further away or are unable to travel, teleconsultation is available for initial review of reports and structured follow-up.

With over 1,500 five-star Google reviews, and an overall five star rating, patients consistently praise the attentive, compassionate care they receive, describing a doctor who truly listens and takes the time to understand their concerns. Every consultation is marked by thorough, easy-to-understand explanations. Patients leave not just with a diagnosis, but with a clear picture of their condition and the path forward. It’s the warmth, kindness, and genuine dedication to each individual that has made Dr Shibal Bhartiya the most trusted glaucoma specialist in Gurgaon.

Address: Marengo Asia Hospitals, Golf Course Extension Road, Sector 56, Gurugram, Haryana

Phone: +91 88826 38735 | +91 98187 00269

Website: www.drshibalbhartiya.com

Already Have a Diagnosis? Consider a Second Opinion

If you have already been diagnosed with glaucoma, or told you are a glaucoma suspect, and something does not feel clear, a structured second opinion may help.

A second opinion is not about doubting your current doctor. It is about protecting a decision that will affect your vision for decades.

→ Visit: drshibalbhartiya.com/glaucoma-second-opinion-gurgaon/

Frequently Asked Questions

1. What is the difference between an ophthalmologist and a glaucoma specialist?

An ophthalmologist is trained in the full scope of eye care. A glaucoma specialist has completed additional fellowship training focused specifically on glaucoma: its diagnosis, progression risk, and management across every stage. For complex, borderline, or long-term glaucoma cases, subspecialist care makes a meaningful difference.

2. How do I know if I need a glaucoma specialist or a routine eye check?

If you have been told your eye pressure is high, your optic nerve looks suspicious, you have a family history of glaucoma, or you have already been diagnosed, a glaucoma specialist is appropriate. Routine eye checks are not designed to detect early glaucoma reliably.

3. Can glaucoma be cured?

Glaucoma cannot be cured, but it can be effectively controlled. With the right treatment and consistent follow-up, most patients with glaucoma maintain good functional vision for life. The goal is not cure but protection of the optic nerve over the long arc of life.

4. Is glaucoma hereditary?

Yes. Having a first-degree relative with glaucoma significantly increases your risk. If a parent or sibling has been diagnosed, a screening evaluation by a glaucoma specialist is recommended — even if you have no symptoms.

5. My vision is normal. Do I still need to worry about glaucoma?

Yes. This is one of the most important misconceptions about glaucoma. Central vision, what you use to read the eye chart, is often preserved until late in the disease. Peripheral vision is lost first, and patients adapt without realising. A glaucoma evaluation tests the optic nerve and visual field, not just visual acuity.

6. I was told to ‘watch and wait.’ Is that appropriate?

Sometimes observation is the right decision, but it should be based on careful risk assessment, not uncertainty. If you are not sure why observation was recommended, or how long to wait and what to watch for, a second opinion consultation can clarify this.

7. Does cataract surgery protect against glaucoma?

Cataract surgery can modestly lower eye pressure, particularly in angle-closure glaucoma. However, it does not cure or prevent glaucoma, and glaucoma monitoring must continue after cataract surgery.

8. What should I bring to my first appointment?

Please bring all previous eye reports including OCT scans, visual field reports, optic nerve photos, eye pressure records, and your current prescriptions. Old reports are particularly valuable as glaucoma diagnosis depends on trends over time. If you do not have reports, come anyway, we can begin assessment from scratch.

A Note on How I Think About Glaucoma Care

Glaucoma rewards early, consistent, careful management, not dramatic late intervention. Most patients who lose vision from glaucoma were doing everything they were told. They were simply diagnosed too late or monitored incorrectly.

My focus is on finding glaucoma early, explaining it clearly, treating it precisely, and following it carefully over time. This is quiet work. But it saves vision.

If you are in Gurgaon or anywhere across Delhi NCR and are looking for a glaucoma specialist who combines international training, research-level expertise, and genuinely patient-centred care, I would be glad to help.

Note: I speak fluent English, Hindi, Urdu and French. I can understand Bangla, Assamese, as well as some Arabic and Spanish. The hospital has interpreters on call, if needed, at no cost to the patient.

Book a Glaucoma Consultation → Call +91 88826 38735 or visit drshibalbhartiya.com

Dr Shibal Bhartiya | Clinical Director, Ophthalmology | Marengo Asia Hospitals, Sector 56, Gurugram

Registration No: HN-15650 | Fellowship: University of Geneva, Switzerland & AIIMS, New Delhi | Research Collaborator: Mayo Clinic, USA

 

OCT and Visual Field

Understanding Glaucoma Investigations: OCT and Visual Field

OCT and Visual Field reports are often confusing. Patients struggle to understand why their doctor has reached a certain diagnosis, or treatment strategy. Many patients receive OCT or visual field reports full of colours and numbers. Both require careful interpretation, and an equally careful explanation.

wGlaucoma diagnosis is rarely based on one scan. Also glaucoma often has no symptoms. It requires understanding patterns over time: how the optic nerve looks, how visual fields change, how eye pressure behaves, and how your individual risk factors fit together.

OCT shows the structure of the optic nerve. Visual field tests show how vision is functioning.
Neither test alone can diagnose glaucoma. This is why reports sometimes seem confusing. A red area on OCT may be normal for a highly myopic eye. An abnormal visual field may simply reflect fatigue or cataract. On the other hand, subtle early glaucoma can be missed if reports are not compared carefully across months and years.

In glaucoma care, numbers do not treat disease. Understanding does.

My approach focuses on calm, structured interpretation of OCT and visual field reports so patients can make informed decisions about long-term eye health. Because glaucoma is usually invisible early, our goal is not only to see clearly today, but to protect vision safely ten years from now.

If your reports are confusing, conflicting, or leading to rushed treatment decisions, a structured glaucoma second opinion can help bring clarity.


Understanding OCT

OCT measures thickness of nerve fibres. Red areas may indicate thinning.

But interpretation depends on:

• age
• myopia
optic nerve size
• machine variability
• baseline comparison

One abnormal OCT does not prove glaucoma. But ignoring subtle changes can be dangerous.


Understanding Visual Fields

Visual field tests measure functional vision.

But results vary with:

• patient attention
• fatigue
• learning effect
• cataract
• dry eye

One abnormal field may not mean disease. Repeated patterns matter more when evaluating progression.


Why OCT and Visual Field Reports Must Be Interpreted Together

Glaucoma diagnosis needs both structure and function. OCT shows nerve structure. Visual field shows vision function. When both OCT and Visual Field show similar changes over time, diagnosis is stronger, and rooted in deeper evidence.


The Importance of Serial Comparison

The most important glaucoma test is comparison.

We compare:

• OCT over years
• visual fields over years
• optic nerve photos

Progression becomes visible only in hindsight. That is why follow-up matters.


Common Misinterpretations

• Red OCT areas in high myopia
• Field defects from cataract
• Machine artefacts
• Ignoring early thinning

You should not panic, or be falsely reassured. What you should ask for is a detailed explanation.


When to Seek Specialist Interpretation

• Conflicting reports
• Advice for surgery
• Multiple drops
• Normal pressure but abnormal OCT
• Strong family history

A structured interpretation can clarify risk.


My Approach

Reports are reviewed systematically with attention to long-term risk.

Patients receive:

• clear explanation
• risk assessment
• management options, including follow up schedule
• missing data list

Because glaucoma care is about continuity, and steady compliance with treatment.

⭐ FAQs – OCT and Visual Field Interpretation

1. My OCT report shows red areas. Does this mean I have glaucoma?

Not always. OCT compares your nerve thickness with an average database.
Red areas can appear in:

• high myopia
• large optic nerves
• normal anatomical variation
• machine artefacts

OCT is only one part of glaucoma diagnosis. It must be interpreted with visual fields, optic nerve exam, and follow-up over time.


2. My visual field test was abnormal once. Should I worry?

A single abnormal visual field does not confirm glaucoma. Visual fields depend on attention, fatigue, dry eye, cataract, and learning effect. Doctors usually repeat the test to confirm a pattern. Consistency over time matters more than one report.


3. Can OCT be normal but glaucoma still present?

Yes. No one test is infallible when it comes to glaucoma diagnosis.

Very early glaucoma can be missed on OCT, especially in normal-tension glaucoma or small optic nerves. This is why clinical examination and follow-up are important. Glaucoma diagnosis is a pattern seen over time, not one scan.


4. Can visual fields be normal if glaucoma is already present?

Yes. Structural nerve damage often occurs before functional loss. Patients may have normal visual fields but abnormal OCT or optic nerve appearance. Early detection focuses on protecting long-term vision before symptoms appear.


5. How often should OCT and visual field tests be repeated?

It depends on your risk of glaucoma progression or vision loss.

• Low risk: once a year
• Glaucoma suspect: every 6–12 months
• Established glaucoma: every 3–6 months

Your doctor decides based on progression risk. Regular comparison (and therefore, regular follow up) is the most important part of glaucoma care.


6. Why do my OCT numbers change between tests?

Small changes happen because of:

• machine differences
• scan alignment and test retest variability
• eye dryness
• cataract
• natural variation

Doctors thus look for consistent trends, not small fluctuations.


7. Can cataract affect visual field results?

Yes.

Cataract can cause diffuse depression on visual field testing. This may look like glaucoma but improves after cataract surgery. This is why reports must be interpreted carefully.


8. My eye pressure is normal. Why do I need OCT and Visual Field?

Many patients have normal-tension glaucoma. Pressure alone cannot rule out disease. OCT and visual field testing help detect subtle nerve damage. Glaucoma diagnosis needs multiple data points, eye pressure is only one of them.


9. Can glaucoma tests (OCT and Visual field) be wrong?

Tests are not “wrong,” but they can be misleading if taken in isolation. Machines measure data. Doctors interpret patterns. Also, visual fields can have fixation losses (you looked away from the fixation light), as well as false positives and false negatives. High rates of any of these can make your visual fields unreliable.

A structured review reduces unnecessary treatment and dangerous delay.


10. When should I seek a glaucoma second opinion?

Consider a second opinion if:

• You are advised surgery suddenly
• Reports are confusing
• Multiple drops are started without explanation
• OCT and visual field results disagree
• Strong family history exists

Clarity helps you make calm, informed decisions.


11. What is the most important glaucoma test?

The most important test is comparison over time. Glaucoma progression becomes visible only when reports are compared across months and years. Continuity of care is essential, and one all clear diagnosis does not mean you don’t need a follow up visit.


12. Can glaucoma be cured if detected early?

Glaucoma cannot be reversed. But early detection and regular care can preserve useful vision for life. The goal is not perfect tests today, but safe vision ten years from now, and always.


Closing Thought

Numbers do not treat glaucoma.
Understanding does.

Protecting vision requires careful interpretation over time.


If you would like your OCT or visual field reports reviewed in a structured glaucoma second opinion:

📞 +91 88826 38735
🌐 drshibalbhartiya.com

Second Opinion Form for teleconsults

Read the research articles

This article has been written by Dr Shibal Bhartiya, a glaucoma specialist in Gurgaon known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. 

She has published peer-reviewed research on OCT and Visual Fields in glaucoma practice, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

These peer-reviewed article discussing OCT and Visual Fields are benchmarks for glaucoma surgeons globally, and can be accessed on PubMed here, here, here, here, and here

Glaucoma • Second Opinion • Advanced Care

🌐 www.drshibalbhartiya.com
📞 +91 88826 38735

Dr Shibal Bhartiya- Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya — Glaucoma Specialist in Gurgaon

Glaucoma surgery

Dr. Shibal Bhartiya: Expert Glaucoma Specialist & Clinician-Scientist

Dr. Shibal Bhartiya is a globally recognized authority in Glaucoma and Neuro-Ophthalmology, currently serving as the Clinical Director at Marengo Asia Hospitals, Gurgaon. She is also a Research Collaborator with Mayo Clinic, Jacksonville, USA. Former Senior Scientific Research Fellow (Glaucoma)  University of Geneva, Switzerland & Former Senior Research Associate (Glaucoma + Cornea), AIIMS, New Delhi. 

With over 27 years of experience, she is one of the few specialists in India who seamlessly bridges the gap between high-volume clinical excellence and international medical research.

At a Glance

🎓 Fellowship trained — University of Geneva, Switzerland & AIIMS New Delhi
🔬 Research Collaborator — Mayo Clinic, Jacksonville, USA 
📚 200+ peer-reviewed publications · 20+ edited textbooks on glaucoma
🏆 Best Research Paper Awards — Asia Pacific Academy of Ophthalmology, Asia Pacific Glaucoma Congress, International Society of Glaucoma Surgery
🏥 Clinical Director, Ophthalmology — Marengo Asia Hospitals, Gurgaon

Academic & Research Distinction

As a Research Collaborator with the Mayo Clinic (Jacksonville, USA), Dr. Bhartiya is at the forefront of global innovations in eye care. Her academic journey includes a prestigious Clinical Research Fellowship in Glaucoma from the University of Geneva, Switzerland, and extensive training at AIIMS, New Delhi.

She is a prolific author of 28 medical textbooks and has published over 200 peer-reviewed research papers in international journals. Her leadership in the field is further cemented as the Executive Editor of the Journal of Current Glaucoma Practice and her role on the Associate Advisory Committee of the International Society of Glaucoma Surgery (ISGS).

Her work can be accessed on Pubmed, Google Scholar, ResearchGate and ORCID.

Patient-Centric Excellence

Beyond her academic accolades, Dr. Bhartiya is arguably the most trusted glaucoma specialist in Gurgaon, maintaining a perfect 5.0-star rating across 1,500+ verified patient reviews. She is widely sought after for ethical glaucoma care and second opinions, specializing in:

  • Evidence-Based, Non-Surgical Protocols
  • Complex Glaucoma Management (Medical & Surgical)
  • Neuro-Ophthalmology & Ocular Surface Diseases
  • Minimally Invasive Glaucoma Surgery (MIGS)

Focus Areas: Providing advanced diagnosis, glaucoma treatment, risk stratification, and second opinions for glaucoma and optic nerve disease. Long-term vision protection.

The Ethical Care Philosophy

Dr. Bhartiya is known for her “patient-first” approach, focusing on long-term vision preservation rather than unnecessary surgical intervention. Her practice is built on transparency, humane care, and the same rigorous standards found at the world’s leading eye institutes.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist  in Gurgaon, currently serving as Clinical Director of Ophthalmology at Marengo Asia Hospitals, Sector 56, Gurugram, and as Research Collaborator at Mayo Clinic, Jacksonville, Florida, USA.

Her clinical focus is glaucoma across its full spectrum- from early detection and borderline disease to complex surgery and second opinions for patients who need clarity on a difficult diagnosis. She also sees patients with neuro-ophthalmological conditions and ocular surface disease.

Dr Bhartiya trained at AIIMS New Delhi, completed a Clinical Research Fellowship in Glaucoma at the University of Geneva, Switzerland, and is currently enrolled for a Doctorate en Médecin at the University of Geneva. Over two decades of glaucoma specialty practice, international research collaboration, and editorial leadership in glaucoma have shaped an approach to care that is careful, long-term, and built around protecting vision, and not just treating numbers.

What I Treat

My practice is focused on patients with glaucoma at every stage — from those who have just been told they may be a glaucoma suspect, to those managing advanced disease after failed surgery. I also see a significant number of patients who come for a structured second opinion, from Gurgaon, NCT and all over India, often after an unclear diagnosis or conflicting advice from different doctors.

Conditions I see regularly: — Primary open-angle glaucoma and normal tension glaucoma — Angle closure glaucoma and angle closure suspects — Ocular hypertension and glaucoma suspects — Secondary glaucomas: steroid-induced, post-uveitic, post-traumatic, after retinal surgery or corneal transplant  Neovascular and complex refractory glaucoma

 Neuro-ophthalmological conditions: optic neuropathy, unexplained visual field loss, optic neuritis, papilledema — Ocular surface disease and dry eye in the context of glaucoma treatment

If you are unsure whether your situation fits, the contact page has details for reaching my coordinator directly. You can also reach me through the Marengo Asia Hospitals appointment page here

Training and Qualifications

Fellowship Training

Clinical Research Fellowship in Glaucoma, Clinique d’Ophtalmologie, Department of Clinical Neurosciences, Hôpitaux Universitaires de Genève, University of Geneva, Switzerland (2010–11).

Also enrolled: Doctorat en Médecin, University of Geneva.

Senior Clinical Research Associate, Cornea and Glaucoma Services, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi (2007–10).

MS Ophthalmology, Maulana Azad Medical College, New Delhi (2007–10).

Current Positions

Clinical Director, Ophthalmology, Marengo Asia Hospitals, Gurugram (July 2024 to date) Program

Director, Community Outreach & Wellness,  Marengo Asia Hospitals, Gurugram and Faridabad

Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)

Research Collaborator, Mayo Clinic, Jacksonville, Florida, USA (September 2024 to date)

Academic and Editorial Leadership

Dr Bhartiya holds editorial positions at three international peer-reviewed journals:

 Editor-in-Chief, Clinical and Experimental Vision and Eye Research 

Editor-in-Chief, Ocular Research Journal

Executive Editor, Journal of Current Glaucoma Practice

She is a Member of the Associate Advisory Committee, International Society of Glaucoma Surgery, and serves on the Delhi Ophthalmic Society International Advisory Sub-Committee.

She has edited more than 20 textbooks in glaucoma and ophthalmology, and contributed chapters to more than 20 others. Her peer-reviewed research is indexed on PubMed and Google Scholar.

Awards and Recognition

Best Paper, Glaucoma Session — APAO, Hyderabad (Continuous IOP Monitoring in Glaucoma)

Best Paper, Glaucoma Session and Top Nine Most Influential Papers — Asia Pacific Glaucoma Congress, Bali 2012 (Diurnal IOP Fluctuation in Angle Closure)

 Multiple best paper recognitions at International Society for Glaucoma Surgery congresses

Global Outreach and Community Work

Beyond clinical practice, Dr Bhartiya has led glaucoma screening and surgical programmes in underserved communities across three continents.

In Egypt, she led a humanitarian mission to Kom Ombo General Hospital, Aswan, conducting screening for over 5,000 patients including children, and provided both medical and surgical management of advanced glaucomas in North Africa. She has also delivered skill-transfer sessions in advanced glaucoma care for doctors, residents, and optometrists in Aswan.

In Switzerland, she designed and executed hospital-based and community glaucoma screening protocols in Geneva and Troinnex, and led screening of United Nations personnel as part of World Glaucoma Week.

In India, she is an active contributor to the Motiabind Mukti Abhiyan cataract outreach programme, has led eye camps in Sirsa (Haryana), and runs school health initiatives and government employee screening programmes in Gurugram.

She is also the founder of Vision Unlimited, a not-for-profit organisation currently running six learning centres in urban Gurugram, serving over 1,200 children with education, nutrition, and healthcare support.

As part of the Eye on the Future program, Vision Unlimited under the guidance of Dr Bhartiya has screened more than 15000 school children; and 5000 elders from underserved areas for refractive errors, and other ocular morbidities. 

Research

Active clinical research collaborations span glaucoma medication adherence, quality of life, IOP monitoring, community-based screening, and surgical outcomes. Dr Bhartiya collaborates with glaucoma specialists across more than 20 countries.

Current trials include work on 24-hour ambulatory IOP monitoring, selective laser trabeculoplasty as primary therapy, tear film osmolarity in glaucoma patients, and quantitative versus qualitative IOP control, as well as metabolic determinants of glaucoma.

Full publication list: PubMed · Google Scholar · Publications page

Book an Appointment

For appointments at Marengo Asia Hospitals, Sector 56, Gurugram, please contact my coordinator at +91 88826 38735.

If you are seeking a structured glaucoma second opinion, you may also use the second opinion form to submit your reports in advance of your consultation.

As a fellowship-trained glaucoma specialist (from University of Geneva, Switzerland, and AIIMS, New Delhi) in Gurgaon, Dr Shibal Bhartiya works with patients across the full spectrum of glaucoma—from suspects and early disease to advanced and complex cases. Her approach emphasises risk stratification, longitudinal follow-up, and calm decision-making, helping patients avoid late surprises and unnecessary interventions.

Patients often seek her care for early glaucoma diagnosis, second opinions, treatment planning, and long-term glaucoma management (medical, glaucoma lasers and glaucoma surgery including MIGS, trabeculectomy and complex tubes and shunts), especially when clarity is needed in uncertain, complex, or borderline cases.

Academic Qualifications:

  • 2010-11 – Clinical Research Fellowship, Glaucoma, University of Geneva, Switzerland
  • 2007-10 – MS (Ophthalmology), Maulana Azad Medical College, New Delhi, India
    1993-99 – M.B.B.S, Maulana Azad Medical College, New Delhi
  • 2000-03 – Clinical Research Associateship, Cornea and Glaucoma, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Doctorate en Medicin, University of Geneva, Switzerland (Currently enrolled)

Experience details:

  • July 2024 to date- Clinical Director, Ophthalmology (MAH, Gurgaon); Program Director, Community Outreach & Wellness (MAH, Gurgaon and Faridabad)
    Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)
  • Sept 2024 to date– Research collaborator, Mayo Clinic, Jacksonville, USA
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2012-July 2024- Director, Additional Director, Sr. Consultant, Consultant – Ophthalmology, Fortis Memorial Research Institute, India

Additional Role

  • Sept 2024 – till date- Research collaborator, Mayo Clinic, Jacksonville, USA
  • August 2015-October 2015- Consultant, Cantahealth, Healthcare Practice, Eliglobal, Charlotte, North Carolina, USA. (Training and development of AI platforms and interfaces in Ophthalmology)
  • Oct 2015- April 2017- Clinical Director, Medflow, Eye Care Leaders (Eliglobal), Charlotte, North Carolina, USA. (Training and development of AI platforms and CDSS interfaces in Ophthalmology)
  • Sept 2012 to Aug 2015 – Consultant, Glaucoma and Preventive Health Services, Department of Ophthalmology, Fortis Memorial Research Institute, Gurgaon, Haryana
  • Sept 2011 to Aug 2012 – Consultant Glaucoma and In charge of Academics and Research, Eye 7 Group of Hospitals, New Delhi
  • Jul 2010 to Jul 2011 – Senior Scientific- Clinical Research Fellow, Glaucoma Sector, Clinique d’ ophthalmologie, Department of Clinical Neurosciences, Glaucoma Sector, Hopitaux Universitaires de Geneve, Switzerland. (Responsibilities including teaching resident doctors and glaucoma fellows)
  • Mar 2007 to Mar 2010 – Senior Research Associate, Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, AIIMS, New Delhi. (Responsibilities including teaching resident doctors)
  • Sept 2003 to Sept 2006 – Senior Registrar, University College of Medical Sciences, and associated Guru Teg Bahadur Hospital, New Delhi. (Responsibilities including teaching resident doctors)

Languages known:

English, Hindi, Urdu, French

Academic, Organisational and Leadership positions:

  • 2024 – Present- Editor in Chief, Ocular Research Journal
  • 2017-to date: Founder, Vision Unlimited, Not for Profit Organization for social responsibility https://vision-unlimited.org/
  • 2019-to date – Editor in Chief –Clinical and Experimental Vision and Eye Research https://www.cleverjournal.org/ https://www.cleverjournal.org/editorial-team/
  • 2016-to date –  Executive Editor – Journal of Current Glaucoma Practice https://www.jocgp.com/journalDetails/JOCGP https://www.jocgp.com/editorialBoard/JOCGP
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2024 to Date- Member, Program Committee, Bal Raksha Bharat, Save the Children, India
  • 2016 to 2021: Executive Editor-DOS Times
  • 2016-till date: Founder Member, Khem, LGBTQ Rights
  • 2009 to 2016 – Managing Editor – Journal of Current Glaucoma Practice
  • 2023 to date- Member, Delhi Ophthalmic Society International advisory sub-committee
  • 2011 – Founding Secretary – Shamms Ed Deen Alcon Glaucoma Fund, University of Geneva, Switzerland
  • 2013 – Member Scientific Committee – World Glaucoma Congress
  • 2012 – Member Scientific Committee – International Society for Glaucoma Surgery
  • 2010 – Member, Organising Committee – International Society for Glaucoma Surgery
  • Apr 2008 to Dec 2009 – Associate Editor – Delhi Journal of Ophthalmology
  • 2008 – Co-Editor – Proceedings of the Strabismic Panorama
  • 2001 to 2003 – Assistant Editor – Indian Journal of Strabismology and Pediatric Ophthalmology
  • 2007 to 2008 – Deputy Editor – Delhi Journal of Ophthalmology
  • Reviewer for several journals worldwide.

Professional Memberships:

  • International Society of Glaucoma Surgery
  • Glaucoma Society of India
  • Strabismological Society of India
  • All India Ophthalmological Society
  • Delhi Ophthalmological Society
  • Haryana Ophthalmological Society
  • Gurugram Ophthalmological Society
  • American Academy of Ophthalmology
  • Association for Research and Vision in Ophthalmology

Community Ophthalmology Programmes:

  • Responsible for design of skill transfer sessions in glaucoma care, and for screening manuals for glaucoma in Africa and the Middle East. Projected collaboration in execution
  • Skill transfer sessions in advanced glaucoma care in Aswan, Egypt for doctors, residents and optometrists
  • Humanitarian mission to Kom Ombo General Hospital, Aswan, Egypt. Screening program for over 5000 patients, including children for glaucoma in Kom Ombo General Hospital, Aswan, Egypt
  • Management, both medical and surgical, of advanced glaucomas in North Africa
  • Screening for glaucoma and designing and execution of protocols and SOPs for hospital based and community outreach programs, Geneva and Troinnex, Switzerland
  • Screening of UN personnel for glaucoma in an outreach exercise as part of World Glaucoma Week in Geneva, Switzerland
  • Actively involved in the Motiabind Mukti Abhiyan, an outreach program for cataract management in India
  • Execution of eye camps in Sirsa, Haryana, as part of a community sponsored initiative
  • School health and eye care initiatives, Gurugram, Haryana
  • Screening programs for police officers and government officials in Gurugram, Haryana
  • Screening programs for community based screening in Pilibhit, UP and Mewat, Haryana

Design of clinical trials:

  • Population based survey of anterior chamber configuration in North African populations
  • Histochemical correlates of chronic glaucoma medication use on trabecular meshwork and ocular surface
  • Persistency, adherence and compliance to glaucoma medications
  • Selective laser trabeculoplasty as primary therapy in an African population: An efficacy and economics perspective
  • Tear film osmolarity studies in patients on glaucoma therapy
  • Comparative evaluation of sclerothalamotomy ab interno combined with phacoemulsification versus phacoemulsification alone in POAG patients
  • Quantitative versus qualitative control of IOP: A risk benefit analysis
  • 24 hour ambulatory IOP monitoring in angle closure glaucoma
  • Effect of increased intraocular pressure on retinal ganglion cells in chick embryos

Awards

  • Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost. Shibal Bhartiya, Aref A, Shaarawy T. APAO, Hyderabad, India. Best Paper, Glaucoma session
  • Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. Asia Pacific Glaucoma Congress 2012, Bali, Indonesia. Best paper glaucoma session, Top nine most influential papers of the congress
  • Harry Potter and the Ophthalmologists Nemesis: Shibal B., S Khokhar, IV International Congress of Glaucoma Surgery, April 2009, Geneva. Best Poster
  • Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. S.Bhartiya, Jayaprakash V, T Dada, A Panda. DOS Annual Conference, March 2009.Best free paper, glaucoma session.
  • Evaluation of levo-dopa as a therapeutic adjunct to conventional occlusion in amblyopia; Kamlesh, Dadeya S, Shibal F. DOS Midcon, 2001 .Best free paper, squint session.
  • Asia ARVO Young Scientists Travel Grant for the year 2008
  • CSIR Young Scientists Travel Grant for the year 2003,2009
  • World Glaucoma Association Young Scientists Travel Grant for the year 2009, 2013Ju

CV

Published Articles